RYLPF - Philips Stock Surges: Risk Remains On Respironics But With Investment Potential
2024-06-28 11:25:08 ET
Summary
- Koninklijke Philips N.V. stock was upgraded from sell to hold in April 2023, jumping 28% due to a settlement regarding apnea devices.
- Despite a €982 million settlement provision for Respironics, adjusted operating income showed improvement in Q1 2024.
- Philips aims for 3-5% sales growth and 11-11.5% EBITDA margin in 2024, with potential significant upside for 2025.
...
Philips Stock Surges: Risk Remains On Respironics, But With Investment Potential